• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical characteristics of pneumonic-type adenocarcinoma of the lung.

作者信息

Wislez Marie, Massiani Marie-Ange, Milleron Bernard, Souidi Abdelkader, Carette Marie-France, Antoine Martine, Cadranel Jacques

机构信息

Laboratoire de Biologie Cellulaire et d'Immunopathologie Pulmonaire, UPRES EA 3493, Université Paris VI, UFR Saint-Antoine, Paris, France.

出版信息

Chest. 2003 Jun;123(6):1868-77. doi: 10.1378/chest.123.6.1868.

DOI:10.1378/chest.123.6.1868
PMID:12796162
Abstract

PURPOSE

To analyze diagnostic approaches, survival predictors, and treatment efficacy in pneumonic-type adenocarcinoma (P-ADC).

PATIENTS AND METHODS

Fifty-two patients with P-ADC diagnosed between January 1986 and December 2000 were studied. P-ADC was defined as histologically or cytologically proven pulmonary adenocarcinoma with a pneumonia-like consolidation, in a patient with no prior diagnosis of thoracic or extrathoracic adenocarcinoma.

RESULTS

Sixty percent of the patients were men (n = 31), and 65% (n = 34) were current or former smokers. Mean (+/- SD) age at diagnosis was 66 +/- 1.4 years. P-ADC was diagnosed by routine chest radiography in 17% of cases (n = 9). Bronchorrhea was present in 31% of cases (n = 16), and crepitant rales in 58% (n = 30). The primary tumor appeared as consolidations, which could not be assessed and were thus classified Tx, in 83% of the patients (n = 43). Ten percent of the patients (n = 5) had a satellite tumor within the lobe containing the primary tumor (T4), and 63% (n = 33) had a satellite tumor in another lobe (M1). Extrathoracic metastases were present in 5% of cases (n = 3). Bronchial biopsy, transbronchial biopsy, bronchial aspiration, and BAL were positive in 21%, 80%, 44%, and 66% of cases, respectively. The median survival time after diagnosis was 10.5 months (range, 1 to 150 months). The outcome of patients treated by lobectomy or bilobectomy was significantly better than that of patients treated with pneumonectomy, chemotherapy, or best supportive care (p < 0.01). Bronchorrhea and crepitant rales were independent predictors of shorter survival when the treatment modality (surgery vs no surgery) was not entered as a risk factor.

CONCLUSIONS

P-ADC is characterized by aerogenous propagation, as emphasized by the results of multivariate analysis showing that bronchorrhea and crepitant rales were the only two independent factors of shorter survival. Surgery remains the most effective treatment in P-ADC, especially when lobectomy is feasible. As CT is not sensitive enough to detect multifocal lesions, new tools are required to evaluate pulmonary involvement and thereby to refine the surgical strategy.

摘要

相似文献

1
Clinical characteristics of pneumonic-type adenocarcinoma of the lung.
Chest. 2003 Jun;123(6):1868-77. doi: 10.1378/chest.123.6.1868.
2
The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases.细支气管肺泡癌及周围型腺癌疾病谱
J Thorac Oncol. 2006 May;1(4):344-59.
3
The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation.肺黏液腺癌伴实变型影像学表现的临床病理分析
Lung Cancer. 2014 Mar;83(3):334-40. doi: 10.1016/j.lungcan.2013.12.016. Epub 2014 Jan 8.
4
Characteristics of elderly patients with COPD and newly diagnosed lung cancer, and factors associated with treatment decision.慢性阻塞性肺疾病(COPD)合并新诊断肺癌老年患者的特征及与治疗决策相关的因素
Int J Chron Obstruct Pulmon Dis. 2016 Jul 4;11:1515-20. doi: 10.2147/COPD.S104670. eCollection 2016.
5
[Outcome of Surgical Treatment of Locally Advanced Lung Cancer after Induction Chemoradiotherapy].[诱导放化疗后局部晚期肺癌的外科治疗结果]
Kyobu Geka. 2018 Apr;71(4):278-283.
6
Bronchoscopic diagnosis of solitary pulmonary nodules and lung masses in the absence of endobronchial abnormality.在无支气管内异常情况下对孤立性肺结节和肺部肿块进行支气管镜诊断。
Chest. 1996 Mar;109(3):620-5. doi: 10.1378/chest.109.3.620.
7
Molecular Alterations in Patients with Pulmonary Adenocarcinoma Presenting with Malignant Pleural Effusion at the First Diagnosis.初诊时伴有恶性胸腔积液的肺腺癌患者的分子改变
Acta Cytol. 2017;61(3):214-222. doi: 10.1159/000477148. Epub 2017 May 25.
8
TS expression predicts postoperative recurrence in adenocarcinoma of the lung.TS 表达预测肺腺癌的术后复发。
Lung Cancer. 2011 Jun;72(3):360-4. doi: 10.1016/j.lungcan.2010.08.024. Epub 2010 Oct 22.
9
A case of rapidly growing pulmonary carcinosarcoma.肺巨细胞癌肉瘤 1 例报告。
Int J Clin Oncol. 2010 Jun;15(3):319-24. doi: 10.1007/s10147-010-0043-z. Epub 2010 Mar 10.
10
[Fiber bronchoscopy in lung cancer: relationship between radiology, endoscopy, histology and diagnostic value in a series of 1801 cases].[纤维支气管镜检查在肺癌中的应用:1801例病例的放射学、内镜检查、组织学及诊断价值之间的关系]
Arch Bronconeumol. 1994 Jun-Jul;30(6):291-6.

引用本文的文献

1
Complex situations in lung cancer: multifocal disease, oligoprogression and oligorecurrence.肺癌中的复杂情况:多灶性疾病、寡进展和寡复发。
Eur Respir Rev. 2024 May 29;33(172). doi: 10.1183/16000617.0200-2023. Print 2024 Apr 30.
2
Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.肺浸润性黏液腺癌的独特复发模式和生存结局:局部治疗在肺内播散中的潜在作用。
Ann Surg Oncol. 2024 Jan;31(1):201-212. doi: 10.1245/s10434-023-14373-8. Epub 2023 Oct 9.
3
Pneumonic type adenocarcinoma: Empirical ATT delaying diagnosis for 1.5 year.
肺型腺癌:经验性抗结核治疗使诊断延迟1.5年。
Med J Armed Forces India. 2023 Sep-Oct;79(5):603-605. doi: 10.1016/j.mjafi.2021.03.021. Epub 2021 Jun 19.
4
Combined model of radiomics and clinical features for differentiating pneumonic-type mucinous adenocarcinoma from lobar pneumonia: An exploratory study.基于影像组学与临床特征的联合模型鉴别黏液型腺泡为主型浸润性腺癌与大叶性肺炎:一项探索性研究
Front Endocrinol (Lausanne). 2023 Jan 16;13:997921. doi: 10.3389/fendo.2022.997921. eCollection 2022.
5
Invasive mucinous adenocarcinoma of the lung: clinicopathological features, F-FDG PET/CT findings, and survival outcomes.肺浸润性黏液性腺癌:临床病理特征、FDG PET/CT 表现及生存结局。
Ann Nucl Med. 2023 Mar;37(3):198-207. doi: 10.1007/s12149-022-01816-7. Epub 2022 Dec 20.
6
Diagnosis and prognosis of acute respiratory distress syndrome related to diffuse pneumonic-type adenocarcinoma: a single-center case series study.弥漫性肺炎型腺癌相关急性呼吸窘迫综合征的诊断与预后:一项单中心病例系列研究。
J Thorac Dis. 2022 Aug;14(8):2812-2825. doi: 10.21037/jtd-22-12.
7
A Severe COVID-19 Pneumonia Revealing a Lepidic Adenocarcinoma: A Diagnostic Challenge during the Pandemic Period.一例暴露出鳞屑样腺癌的重症新型冠状病毒肺炎:大流行期间的诊断挑战
Am J Respir Crit Care Med. 2022 Feb 1;205(3):357-359. doi: 10.1164/rccm.202104-0826IM.
8
Comparative study of imaging and pathological evaluation of pneumonic mucinous adenocarcinoma.肺炎性黏液腺癌的影像学与病理评估的对比研究
Oncol Lett. 2021 Feb;21(2):125. doi: 10.3892/ol.2020.12386. Epub 2020 Dec 17.
9
Typical presentation of pulmonary lepidic adenocarcinoma: a rare case report.肺鳞屑状腺癌的典型表现:一例罕见病例报告
Pan Afr Med J. 2020 May 11;36:11. doi: 10.11604/pamj.2020.36.11.22660. eCollection 2020.
10
Adenocarcinoma of the lung: from BAC to the future.肺癌腺癌:从细支气管肺泡癌到未来
Insights Imaging. 2020 May 19;11(1):69. doi: 10.1186/s13244-020-00875-6.